Literature DB >> 34247159

Metabolic Regulation of Macrophage Activation.

Ourania Kolliniati1,2,3, Eleftheria Ieronymaki1,3, Eleni Vergadi2, Christos Tsatsanis1,3.   

Abstract

Macrophages, the central mediators of innate immune responses, being in the first-line of defense, they have to readily respond to pathogenic or tissue damage signals to initiate the inflammatory cascade. Such rapid responses require energy to support orchestrated production of pro-inflammatory mediators and activation of phagocytosis. Being a cell type that is present in diverse environments and conditions, macrophages have to adapt to different nutritional resources. Thus, macrophages have developed plasticity and are capable of utilizing energy at both normoxic and hypoxic conditions and in the presence of varying concentrations of glucose or other nutrients. Such adaptation is reflected on changes in signaling pathways that modulate responses, accounting for the different activation phenotypes observed. Macrophage metabolism has been tightly associated with distinct activation phenotypes within the range of M1-like and M2-like types. In the context of diseases, systemic changes also affect macrophage metabolism, as in diabetes and insulin resistance, which results in altered metabolism and distinct activation phenotypes in the adipose tissue or in the periphery. In the context of solid tumors, tumor-associated macrophages adapt in the hypoxic environment, which results in metabolic changes that are reflected on an activation phenotype that supports tumor growth. Coordination of environmental and pathogenic signals determines macrophage metabolism, which in turn shapes the type and magnitude of the response. Therefore, modulating macrophage metabolism provides a potential therapeutic approach for inflammatory diseases and cancer.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cancer; Diabetes; Inflammation; Insulin; Macrophage; Metabolism; Obesity

Mesh:

Year:  2021        PMID: 34247159      PMCID: PMC8787535          DOI: 10.1159/000516780

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  158 in total

1.  Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2.

Authors:  Kaustav Das Gupta; Melanie R Shakespear; James E B Curson; Ambika M V Murthy; Abishek Iyer; Mark P Hodson; Divya Ramnath; Vikas A Tillu; Jessica B von Pein; Robert C Reid; Kathryn Tunny; Daniel M Hohenhaus; Shayli Varasteh Moradi; Gregory M Kelly; Takumi Kobayashi; Jennifer H Gunter; Alexander J Stevenson; Weijun Xu; Lin Luo; Alun Jones; Wayne A Johnston; Antje Blumenthal; Kirill Alexandrov; Brett M Collins; Jennifer L Stow; David P Fairlie; Matthew J Sweet
Journal:  Cell Rep       Date:  2020-02-25       Impact factor: 9.423

2.  Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation.

Authors:  Shannon E Mullican; Christine A Gaddis; Theresa Alenghat; Meera G Nair; Paul R Giacomin; Logan J Everett; Dan Feng; David J Steger; Jonathan Schug; David Artis; Mitchell A Lazar
Journal:  Genes Dev       Date:  2011-12-01       Impact factor: 11.361

3.  Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization.

Authors:  Alicia Arranz; Christina Doxaki; Eleni Vergadi; Yeny Martinez de la Torre; Katerina Vaporidi; Eleni D Lagoudaki; Eleftheria Ieronymaki; Ariadne Androulidaki; Maria Venihaki; Andrew N Margioris; Efstathios N Stathopoulos; Philip N Tsichlis; Christos Tsatsanis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

4.  Autophagy differentially regulates macrophage lipid handling depending on the lipid substrate (oleic acid vs. acetylated-LDL) and inflammatory activation state.

Authors:  Sapir Hadadi-Bechor; Yulia Haim; Tal Pecht; Roni Gat; Tanya Tarnovscki; Martin Gericke; Assaf Rudich
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-09-12       Impact factor: 4.698

5.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation.

Authors:  Shinya U Amano; Jessica L Cohen; Pranitha Vangala; Michaela Tencerova; Sarah M Nicoloro; Joseph C Yawe; Yuefei Shen; Michael P Czech; Myriam Aouadi
Journal:  Cell Metab       Date:  2013-12-26       Impact factor: 27.287

Review 6.  The Role of Macrophage Lipophagy in Reverse Cholesterol Transport.

Authors:  Se Jin Jeong; Mi Ni Lee; Goo Taeg Oh
Journal:  Endocrinol Metab (Seoul)       Date:  2017-03

Review 7.  A review on the biology and properties of adipose tissue macrophages involved in adipose tissue physiological and pathophysiological processes.

Authors:  Yunjia Li; Ke Yun; Runqing Mu
Journal:  Lipids Health Dis       Date:  2020-07-09       Impact factor: 3.876

Review 8.  Glycolysis - a key player in the inflammatory response.

Authors:  Gonzalo Soto-Heredero; Manuel M Gómez de Las Heras; Enrique Gabandé-Rodríguez; Jorge Oller; María Mittelbrunn
Journal:  FEBS J       Date:  2020-04-27       Impact factor: 5.542

9.  M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.

Authors:  Xiang-Yang Zeng; Hui Xie; Jing Yuan; Xiao-Yan Jiang; Jia-Hui Yong; Da Zeng; Ying-Yu Dou; Song-Shu Xiao
Journal:  Cancer Biol Ther       Date:  2019-05-07       Impact factor: 4.742

10.  Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation.

Authors:  Jade D Bailey; Marina Diotallevi; Thomas Nicol; Eileen McNeill; Andrew Shaw; Surawee Chuaiphichai; Ashley Hale; Anna Starr; Manasi Nandi; Elena Stylianou; Helen McShane; Simon Davis; Roman Fischer; Benedikt M Kessler; James McCullagh; Keith M Channon; Mark J Crabtree
Journal:  Cell Rep       Date:  2019-07-02       Impact factor: 9.423

View more
  6 in total

1.  Immunometabolism: Where Immunology and Metabolism Meet.

Authors:  Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-12-14       Impact factor: 7.349

2.  Expression of O-glycosylated oncofetal fibronectin in alternatively activated human macrophages.

Authors:  Marcos Andre Rodrigues da Costa Santos; Jhenifer Santos Dos Reis; Carlos Antonio do Nascimento Santos; Kelli Monteiro da Costa; Pedro Marçal Barcelos; Karen Queiroz de Oliveira Francisco; Pedro Antônio Guimarães Notaroberto Barbosa; Emanuelle Damasceno Souza da Silva; Celio Geraldo Freire-de-Lima; Alexandre Morrot; Debora Decote-Ricardo; Israel Diniz-Lima; Jose Osvaldo Previato; Lucia Mendonca-Previato; Leonardo Marques da Fonseca; Leonardo Freire-de-Lima
Journal:  Immunol Res       Date:  2022-10-05       Impact factor: 4.505

3.  Diabetes-Induced Changes in Macrophage Biology Might Lead to Reduced Risk for Abdominal Aortic Aneurysm Development.

Authors:  Giulia Chinetti; Joseph Carboni; Joseph Murdaca; Claudine Moratal; Brigitte Sibille; Juliette Raffort; Fabien Lareyre; Elixène Jean Baptiste; Réda Hassen-Khodja; Jaap G Neels
Journal:  Metabolites       Date:  2022-01-29

Review 4.  One Molecule for Mental Nourishment and More: Glucose Transporter Type 1-Biology and Deficiency Syndrome.

Authors:  Romana Vulturar; Adina Chiș; Sebastian Pintilie; Ilinca Maria Farcaș; Alina Botezatu; Cristian Cezar Login; Adela-Viviana Sitar-Taut; Olga Hilda Orasan; Adina Stan; Cecilia Lazea; Camelia Al-Khzouz; Monica Mager; Mihaela Adela Vințan; Simona Manole; Laura Damian
Journal:  Biomedicines       Date:  2022-05-26

Review 5.  Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases.

Authors:  Gerhard Paul Püschel; Julia Klauder; Janin Henkel
Journal:  J Clin Med       Date:  2022-07-27       Impact factor: 4.964

Review 6.  Gut Microbiota, Macrophages and Diet: An Intriguing New Triangle in Intestinal Fibrosis.

Authors:  Asma Amamou; Cian O'Mahony; Mathilde Leboutte; Guillaume Savoye; Subrata Ghosh; Rachel Marion-Letellier
Journal:  Microorganisms       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.